Cannabis Testing Market Segmentation:
Test Segment Analysis
Pesticide screening segment is estimated to hold more than 23% cannabis testing market share by 2035. Because of the significant health problems related to pesticide users, many governments allow the implementation of specific pesticides with limitations. These pesticides are directed for use on a cannabis plant for cannabis testing in many countries.
As stated by the European Environment Agency, at 25% of all monitoring locations in rivers and lakes throughout Europe in 2021, one or more pesticides were found to be above limits of concern. A 2019 research that analyzed agricultural soils found pesticide residues in 84% of the samples.
Technology Segment Analysis
By 2035, chemotherapy segment is expected to hold more than 70% cannabis testing market share. This expansion will be noticed due to the increasing use of chemotherapy globally and the rising popularity of cannabis testing as they provide prompt and precise outcomes.
According to a recent study, there will be a 53% increase in the number of people worldwide who require chemotherapy between 2018 and 2040, from 9.8 million to 15 million. Cancer patients are becoming more and more interested in the possible benefits of using the age-old plant in their treatment plans as more states allow medicinal marijuana.
Our in-depth analysis of the global cannabis testing market includes the following segments:
|
Test |
|
|
Technology |
|
|
End-Use |
|
|
Product & Software |
|
|
Portability |
|
